Christie Binder, M.D., Ph.D.

The search for liver cancer biomarkers: Christie Binder In the Lab

For now, liver transplant is the only cure for hepatocellular carcinoma, the most common liver cancer in the United States. Patients with cirrhosis are most likely to develop hepatocellular...

V Foundation cancer research funding, internal deadline March 1

The V Foundation for Cancer Research - Translational Awards provide up to $200,000 per year for three years to fund projects that intend to develop novel, translational approaches to the prevention,...

Rita Allen Foundation Scholar Award, internal deadline Nov. 15

The Rita Allen Foundation Scholars Program supports research scientists in the early stages of their careers. Fields of research are cancer, immunology and neuroscience. Individuals chosen will be...

New research shows search and destroy function for leukemia cells

The rapid growth of leukemia cells that “crowd out” healthy stem cells within the bone marrow has traditionally been considered the root cause for prolonged risk of infections and necessary blood...

Two new NCI funding opportunities with upcoming deadlines

The National Cancer Institute released two funding announcements in recent weeks that offer exciting opportunities for investigators to improve patient outcomes and contribute major breakthroughs in...

Knight Cancer Institute researchers track metastasis with cell-free DNA

Researchers at the OHSU Knight Cancer Institute recently found that sequencing the fragments of tumor DNA that circulate in blood may give a more accurate picture of a patient’s metastatic cancer...

Internal applications for Mary Kay Cancer Research Award due Dec. 19

The purpose of the Mary Kay Ash Foundation Innovative/Translational Cancer Research Award is to fund research in ovarian, uterine, breast, or cervical cancer. Translational research is broadly...